• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病中的尿nephrin相关肾病

Urinary nephrin linked nephropathy in type-2 diabetes mellitus.

作者信息

Rangaswamaiah Hareesh, Somashekar Pallavi, Gutlur Nagarajaiah Setty Raghav, Ganesh Veluri

机构信息

Department of General Medicine, Akash Institute of Medical Sciences and Research Centre, Bangalore - 562110, Karnataka, India.

Department of General Medicine, Rajarajeswari Medical College and Hospital, Bangalore - 560074, Karnataka, India.

出版信息

Bioinformation. 2022 Dec 31;18(12):1131-1135. doi: 10.6026/973206300181131. eCollection 2022.

DOI:10.6026/973206300181131
PMID:37701508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10492904/
Abstract

Diabetic nephropathy is a one of the risk factor for end stage renal disease in patients with type 2 diabetes mellitus. Urinary micr oalbumin currently marker using for diagnosis of nephropathy in type 2 diabetes mellitus due to its larger variability and less specificity. Urinary nephrin is podocyte protein can be act as a early predictable and prognostic marker than micro albumin for nephropathy in type 2 diabetes mellitus. This case-control prospective observational study included 60 type 2 diabetes mellitus and 30 controls after applying criteria. Basic biochemical, clinical and experimental data were measured and recorded. There was a significantly elevated level of urinary nephrin in type 2 diabetes mellitus patients when compared to controls. The urinary nephrin significantly elevated in normo albuminuria group only when compared to urinary ACR and it is positive association with kidney damage. This study concluded significantly elevated levels of urinary nephrin might be used for early diagnosis and prognostic marker for nephropathy in type 2 diabetes mellitus.

摘要

糖尿病肾病是2型糖尿病患者终末期肾病的危险因素之一。由于尿微量白蛋白变异性较大且特异性较低,目前它是用于诊断2型糖尿病肾病的标志物。尿nephrin是一种足细胞蛋白,对于2型糖尿病肾病而言,它可作为比微量白蛋白更早的预测和预后标志物。这项病例对照前瞻性观察研究纳入了60例2型糖尿病患者和30例符合标准后的对照。测量并记录了基本生化、临床和实验数据。与对照组相比,2型糖尿病患者的尿nephrin水平显著升高。仅与尿ACR相比时,正常白蛋白尿组的尿nephrin显著升高,且它与肾损伤呈正相关。本研究得出结论,尿nephrin水平显著升高可能用于2型糖尿病肾病的早期诊断和预后标志物。

相似文献

1
Urinary nephrin linked nephropathy in type-2 diabetes mellitus.2型糖尿病中的尿nephrin相关肾病
Bioinformation. 2022 Dec 31;18(12):1131-1135. doi: 10.6026/973206300181131. eCollection 2022.
2
Urinary Nephrin is a Sensitive Marker to Predict Early Onset of Nephropathy in Type 2 Diabetes Mellitus.尿 Nephrin 是预测 2 型糖尿病肾病早期发病的敏感标志物。
J Lab Physicians. 2022 Oct 26;14(4):497-504. doi: 10.1055/s-0042-1757718. eCollection 2022 Dec.
3
A Study of Association of Urinary Nephrin with Albuminuria in Patients with Diabetic Nephropathy.糖尿病肾病患者尿中nephrin与蛋白尿相关性的研究
Indian J Nephrol. 2021 Mar-Apr;31(2):142-148. doi: 10.4103/ijn.IJN_305_19. Epub 2021 Feb 23.
4
Proximal tubule dysfunction is associated with podocyte damage biomarkers nephrin and vascular endothelial growth factor in type 2 diabetes mellitus patients: a cross-sectional study.近端肾小管功能障碍与2型糖尿病患者足细胞损伤生物标志物nephrin和血管内皮生长因子相关:一项横断面研究。
PLoS One. 2014 Nov 14;9(11):e112538. doi: 10.1371/journal.pone.0112538. eCollection 2014.
5
Utility of Urinary Nephrin in Patients With and Without Diabetic Nephropathy and Its Correlation With Albuminuria.尿nephrin在糖尿病肾病患者和非糖尿病肾病患者中的应用及其与蛋白尿的相关性。
Cureus. 2021 Dec 2;13(12):e20102. doi: 10.7759/cureus.20102. eCollection 2021 Dec.
6
Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study.2 型糖尿病糖尿病肾病中失调的 Nephrin:一项横断面研究。
PLoS One. 2012;7(5):e36041. doi: 10.1371/journal.pone.0036041. Epub 2012 May 17.
7
Urinary nephrin is earlier, more sensitive and specific marker of diabetic nephropathy than microalbuminuria.与微量白蛋白尿相比,尿nephrin是糖尿病肾病更早、更敏感且更具特异性的标志物。
J Med Biochem. 2020 Jan 10;39(1):83-90. doi: 10.2478/jomb-2019-0026.
8
Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes.糖尿病正常白蛋白尿患者足细胞标志物尿排泄增加。
Nephron. 2015;131(1):34-42. doi: 10.1159/000438493. Epub 2015 Sep 5.
9
Messenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathy.不同糖耐量程度伴或不伴肾病患者足细胞相关蛋白的信使核糖核酸水平
BMC Nephrol. 2013 Oct 8;14:214. doi: 10.1186/1471-2369-14-214.
10
A Study of the Risk Factors and Urinary Podocin as an Early Prognostic Indicator of Renal Injury in Diabetic Nephropathy.糖尿病肾病中肾损伤的早期预后指标——尿足细胞的风险因素研究。
J Assoc Physicians India. 2021 Jun;69(6):11-12.

引用本文的文献

1
The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Increased Glomerular Production or Permeability in Diabetes Mellitus?尿液中的人磷脂酶B-II前体(HPLBII-P)能否作为糖尿病中肾小球生成增加或通透性增加的新型生物标志物?
J Clin Med. 2024 Apr 30;13(9):2629. doi: 10.3390/jcm13092629.

本文引用的文献

1
Linking adiponectin expression and kidney dysfunction among Indian patients with and without diabetic nephropathy.印度糖尿病肾病患者与非糖尿病肾病患者中脂联素表达与肾功能不全的关联
Bioinformation. 2022 Oct 31;18(10):876-883. doi: 10.6026/97320630018876. eCollection 2022.
2
Utility of Urinary Nephrin in Patients With and Without Diabetic Nephropathy and Its Correlation With Albuminuria.尿nephrin在糖尿病肾病患者和非糖尿病肾病患者中的应用及其与蛋白尿的相关性。
Cureus. 2021 Dec 2;13(12):e20102. doi: 10.7759/cureus.20102. eCollection 2021 Dec.
3
Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.评估 2 型糖尿病肾病患者的两种新型肾小管蛋白。
J Investig Med. 2020 Mar;68(3):748-755. doi: 10.1136/jim-2019-001135. Epub 2019 Nov 12.
4
Regulation of Nephrin Phosphorylation in Diabetes and Chronic Kidney Injury.糖尿病及慢性肾脏损伤中 Nephrin 磷酸化的调节。
Adv Exp Med Biol. 2017;966:149-161. doi: 10.1007/5584_2017_62.
5
Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.用于早期糖尿病肾病评估的尿液生物标志物
J Diabetes Res. 2016;2016:4626125. doi: 10.1155/2016/4626125. Epub 2016 Jun 16.
6
Biomarkers of rapid chronic kidney disease progression in type 2 diabetes.2 型糖尿病慢性肾脏病快速进展的生物标志物。
Kidney Int. 2015 Oct;88(4):888-96. doi: 10.1038/ki.2015.199. Epub 2015 Jul 22.
7
Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients.2 型糖尿病患者早期糖尿病肾病的尿液生物标志物。
Biomark Res. 2015 Jul 4;3:16. doi: 10.1186/s40364-015-0042-3. eCollection 2015.
8
Novel therapies for diabetic kidney disease.糖尿病肾病的新型疗法。
Adv Chronic Kidney Dis. 2014 Mar;21(2):121-33. doi: 10.1053/j.ackd.2014.01.007.
9
Markers of and risk factors for the development and progression of diabetic kidney disease.糖尿病肾病的发生和进展的标志物及危险因素。
Am J Kidney Dis. 2014 Feb;63(2 Suppl 2):S39-62. doi: 10.1053/j.ajkd.2013.10.048.
10
AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.AGEs,而不是高血糖,是糖尿病微血管并发症的罪魁祸首:一种“糖基化中心”的观点。
Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):913-9. doi: 10.1016/j.numecd.2013.04.004. Epub 2013 Jun 17.